Experts

Experts

Field
Renate Hahn

Global Strategic Advisor
Healthcare Professional

Business Strategy , Cardiology , Diabetes , Hematology , Obesity , Operations , Pharma & Biotech , Product Launches , Rare Diseases
  • Business professional and pharmacist 30+ years of leadership experience in the healthcare industry globally.
  • Successfully launched global portfolios across therapeutic areas including diabetes, obesity, hematology, and rare diseases.
  • Gained broad functional experiences internationally during her tenure at Eli-Lilly, Sanofi, Zydus, Novo Nordisk and Takeda while living in various countries.
Klaus Beck

MD, PhD, PhD
Global Strategic and Operational R&D Leader
Experienced Chief Medical Officer

Commercialization , Cross-cultural , Integrative Team Building and Management , Partnerships & Business Development , R&D , Team Management
  • Physician and dual PhD scientist with over 30 years of experience leading R&D commercialization and business development at global biotech/pharma companies.
  • Key leadership roles at Genentech, Merck & Co/MSD, Amgen, AstraZeneca, Amgen Astellas Biopharma, and Organon & Co, currently freelance consultant with a broad, comprehensive pharma/biotech commercialization perspective.
  • Started up local and regional affiliates, led teams of up to 850 people and budgets up to $250M across the U.S., Europe, and Asia.
Nadya Brady

Associate Director, Analytical Development and CMC

Pharmaceutical development , Phase 1 - 3 prep , R&D , Regulatory
  • 20 years’ experience in discovery and clinical drug development across multiple therapeutic areas
  • Led pre-clinical and clinical analytical strategy, drug discovery and clinical development efforts to support therapeutic and preventative development, namely vaccines
  • Managed diverse analytical development and matrixed teams at small and large pharma and biotech companies, GSK, GreenLight Bio, and Nitto Denko Avecia
Nathan Kaiser

Swiss Attorney-at-Law Cross-Border Legal Strategis

Company structuring , Expansion , Legal , Regulatory
  • 25 years of global legal experience spanning Switzerland, China, Hong Kong, Taiwan and USA
  • Nathan specializes in advising companies on legal structuring, international expansion, and regulatory strategy.
  • Held pivotal roles at organizations such as Eiger, SACC, Audemars Piguet, Cardano Foundation, SIX Digital Exchange to name a few.
Andreea Stanescu

Business Transformation Archietect & Founder

Financial modelling , Funding Support , Growth , M&A prep , Scaleup operations
  • 20+ years enabling growth and strategy for multinational medical device and pharmaceutical companies
  • Guiding SMEs through complex growth and change landscapes, M&A, and integration challenges
  • Tailored mentorship and consulting for startups to deliver measurable growth and financial performance
Brian Magierski

MBA
Global Entrepreneur in Blockchain & Healthy Lifestyle

Business Strategy , Deal Making , Entrepreneurship , Fund Raising , Software Development
  • Global tech entrepreneur with 25+ years building and scaling companies in blockchain, enterprise software, and health-tech across the U.S., Europe, and Asia
  • Raised hundreds of millions in venture capital and led multiple high-value exits, including the $340M sale of iMark.com, later acquired by SAP
  • Currently cofounder at Cerebrum DAO and cofounder of Offchain Global Zurich Chapter; previously cofounder/managing partner at Pacific Springboard with deep expertise in startup growth, fundraising, and cross-border strategy
Alberto Nobili

PhD, Program Head, Serial Biotech Entrepreneur

Biotech Startup Building , CGT Strategy , Company Building , Investment Diligence , Venture Scouting
  • Scientist and entrepreneur with over 8 years of experience advancing Cell and Gene Therapy (CGT) technologies from lab to market.
  • Offers expertise in building relations with pharma, scaling startups, and deep research expertise especially in the fields of CGT & cancer.
  • Currently Head of Bayer Co.Lab Cambridge, where he scouts and supports high-potential biotech startups for partnerships and investment. Co-founded Dynamic Cell Therapies (Next-Gen CAR-T) and 42N Advisors (strategic support for biotech ventures). Former researcher at Harvard Medical School
Selina Gurri

PhD, Business Developer Healthcare

Assay Development , Biology , Experimental Design , Microphysiological Systems , Microscopy Imaging and Analysis
  • 10+ years’ experience driving R&D and innovation across multiple therapeutic areas in academia, biotech and pharma
  • Led successful projects and collaborations spanning academia, startups, and industry partners, including assay and imaging platform development
  • Held research roles at world-leading institutions including ETH Zürich and Harvard Medical School/Massachusetts General Hospital
Request a Meeting
*Maximum 200 characters
Cancel
Send